Serenoa Repens, lycopene and selenium: a triple therapeutic approach to manage benign prostatic hyperplasia

Minutoli, L., Bitto, A., Squadrito, F., Marini, H., Irrera, N., Morgia, G., Passantino, A. and Altavilla, D. · Current Medicinal Chemistry · 2013

Meta-analysis / review

View original source →

Abstract

This review describes Serenoa repens combined with lycopene and selenium as a triple therapeutic approach for benign prostatic hyperplasia, targeting prostatic proliferation and inflammation.

Referenced for these plants

How to cite

Minutoli, L., Bitto, A., Squadrito, F., Marini, H., Irrera, N., Morgia, G., Passantino, A. and Altavilla, D (2013) 'Serenoa Repens, lycopene and selenium: a triple therapeutic approach to manage benign prostatic hyperplasia', Current Medicinal Chemistry, 20(10), pp. 1306-1312. doi:10.2174/0929867311320100007

This reference is part of the evidence base for the Omnia Sana plant database. Source links open the original publication; Omnia Sana does not host third-party content.